Spectroscopic Analysis of Tongue Tumor Samples.
Prospective Analysis of Tumor Tissues From the Oral Cavity by SpiderMassTM Spectroscopy
Centre Hospitalier Universitaire, Amiens
33 participants
Mar 10, 2021
OBSERVATIONAL
Conditions
Summary
In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally represents the primary treatment strategy. Among factors determining the disease prognostic, the surgical margins status is essential for the continued management of the patient, with or without complementary therapies. Generally, surgical margins are defined using visual and tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive after histopathological examination, on average 5 to 7 days post-surgery. Techniques have recently been developed to analyze the cancerous and non-cancerous nature of tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical tool to precisely define cancerous areas in situ and the margins status in intraoperative conditions. Based on the principle of artificial intelligence, the SpiderMass™ machine must initially learn to recognize pathological tissues versus healthy. This project aims to accomplish this first phase of machine learning for squamous cell carcinoma of the tongue.
Eligibility
Inclusion Criteria4
- age : 18 years and older
- squamous cell carcinoma of the tongue
- surgical resection as first-line treatment
- tumor classification T1 to T4.
Exclusion Criteria2
- metastatic disease
- neoadjuvant therapies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In squamous cell carcinoma of the tongue, complete surgical resection of the tumor
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05104619